Skip to main content
SpringerLink
Log in

Central serous retinopathy associated with adrenocorticotrophic hormone therapy

A case report and a hypothesis

  • Clinical Investigation
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

Abstract

• Background: Central serous retinopathy (CSR) has been linked by several authors to the therapeutic use of adrenocorticotrophic hormone (ACTH) or corticosteroids or to endogenous ACTH hypersecretion. Various pathogenic mechanisms have been suggested to explain this phenomenon; all relate to the steroids as the causative agents. • Case report: A simultaneous, bilateral central serous retinopathy developed in a woman treated by intramuscular injections of a synthetic ACTH analog for arthritis. The condition resolved 2 months after stopping the use of this drug. • Discussion: Many investigators consider CSR to be either a disorder of the retinal pigment epithelium (RPE) ion-pump function or a result of choroidal vascular hyperpermeability. ACTH has a melanotrophic part, melanocyte-stimulating hormone (MSH), that may affect RPE cells, which are melanin-pigmented cells of neuroectoderm origin, and alter their ionic pumping properties. This is supported by evidence in the literature for the effect of MSH on animal RPE cells, as well as on other secreting epithelia. MSH is known to act through increasing intracellular CAMP levels. Based on the current concepts regarding the pathogenesis of CSR, two possible mechanisms for ACTH/MSH-associated CSR are suggested. In the first, MSH increases intracellular cAMP levels in RPE cells, thereby inducing pump dysfunction and a reversal of ionic current direction, leading to subretinal fluid accumulation. An alternative mechanism is based on the known ability of MSH to increase the permeability of blood-aqueous and blood-brain barriers. It is hypothesized that MSH disrupts the outer blood-retinal barrier or causes leakage from choroidal vessels.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Abramowicz I (1970) Retinochoriopathy and adrenocortical crisis (Addison's disease) Pathological investigation. Klin Oczna 40: 99–101

    PubMed  Google Scholar 

  2. Ances IG, Pomerantz SH (1974) Serum concentrations of betamelanocyte-stimulating hormone in human pregnancy. Am J Obstet Gynecol 119: 1062–1068

    PubMed  Google Scholar 

  3. Anjou CIN, Karakau CET, Stigmar G (1961) Effect of some pituitary preparations on the normal flare density in rabbits' eyes. Acta Ophthalmol (Copenh) 39: 874–882

    Google Scholar 

  4. Banks WA, Kastin AJ (1995) Permeability of the blood brain barrier to melanocortins. Peptides 16: 1157–1161

    PubMed  Google Scholar 

  5. Bedrossian RH (1974) Central serous retinopathy and pregnancy. (Letter) Am J Ophthalmol 78: 152

    PubMed  Google Scholar 

  6. Bengtsson E (1976) The effect of imidazole on the disruption of the bloodaqueous barrier in the rabbit eye. Invest Ophthalmol 15: 315–320

    PubMed  Google Scholar 

  7. Bengtsson E (1977) The effect of theophylline on the breakdown of the blood-aqueous barrier in the rabbit eye. Invest Ophthalmol Vis Sci 16: 636–640

    PubMed  Google Scholar 

  8. Bouzas EA, Scott MH, Mastorakos G, Chrousos GP, Kaiser-Kupfer MI (1993) Central serous chorioretinopathy in endogenous hypercortisolism. Arch Ophthalmol 111: 1229–1233

    PubMed  Google Scholar 

  9. Chumbley LC, Frank RN (1974) Central serous retinopathy and pregnancy. Am J Ophthalmol 77: 158–160

    PubMed  Google Scholar 

  10. Clark D, Thody AJ, Shuster S, Bowers H (1978) Immunoreactive alphaMSH in human plasma in pregnancy. Nature 273: 163–164

    PubMed  Google Scholar 

  11. Daniele S, Schepens C, Daniele C, Angeletti G (1995) Fundus abnormalities in Cushing's disease: a preliminary report. Ophthalmologica 209: 88–91

    PubMed  Google Scholar 

  12. Dyster-Aas K, Krakau CET (1964) Increased permeability of the bloodaqueous barrier in the rabbit's eye provoked by melanocyte stimulating peptides. Endocrinology 74: 255–265

    PubMed  Google Scholar 

  13. Gass JDM (1991) Central serous chorioretinopathy and white subretinal exudation during pregnancy. Arch Ophthalmol 109: 677–681

    PubMed  Google Scholar 

  14. Gass JDM, Little H (1995) Bilateral bullous exudative retinal detachment complicating idiopathic central serous chorioretinopathy during systemic corticosteroid therapy. Ophthalmology 102: 737–747

    PubMed  Google Scholar 

  15. Goodall T, Buffey JA, Rennie IG, Benson M, Parsons MA, Faulkner MK, MacNeil S (1994) Effect of melanocyte stimulating hormone on human cultured choroidal melanocytes, uveal melanoma cells, and retinal epithelial cells. Invest Ophthalmol Vis Sci 35: 826–837

    PubMed  Google Scholar 

  16. Guyer DR, Yannuzzi LA, Slakter JS, Sorenson JA, Ho A, Orlock D (1994) Digital indocyanine green videoangiography of central serous chorioretinopathy. Arch Ophthalmol 112: 1057–1062

    PubMed  Google Scholar 

  17. Hayashi K, Hasegawa Y, Tokoro T (1986) Indocyanine green angiography of central serous chorioretinopathy. Int Ophthalmol 9: 37–41

    PubMed  Google Scholar 

  18. Hughes BA, Miller SS, Joseph DP, Edelman JL (1988) cAMP stimulates the Na+-K+ pump in frog retinal pigment epithelium. Am J Physiol 254: C84–98

    PubMed  Google Scholar 

  19. Ilan AB, Savion N, Naveh N (1992) Alpha melanocyte stimulating hormone enhances eicosanoid production by bovine retinal pigment epithelium. Prostaglandins 43: 31–44

    PubMed  Google Scholar 

  20. Jain IS, Singh K (1966) Maculopathy: a corticosteroid side-effect. J All India Ophthalmol Soc 14: 250–252

    PubMed  Google Scholar 

  21. Marmor MF (1988) New hypothesis on the pathogenesis and treatment of serous retinal detachment. Graefe's Arch Clin Exp Ophthalmol 226: 548–552

    Google Scholar 

  22. Marmor MF, Negi A (1986) Pharmacologic modification of subretinal fluid absorption in the rabbit eye. Arch Ophthalmol 104: 1674–1677

    PubMed  Google Scholar 

  23. Miller SS, Hughes BA, Machen TE (1982) Fluid transport across retinal pigment epithelium is inhibited by AMP. Proc Natl Acad Sci USA 79: 2111–2115

    PubMed  Google Scholar 

  24. Orias R, McCann SM (1972) Natriuresis induced by alpha and beta melanocyte stimulating hormone (MSH) in rats. Endocrinology 90: 700–706

    PubMed  Google Scholar 

  25. Pawelek JM (1985) Studies on the Claudman melanoma cell line as a model for the action of MSH. Yale J Biol Med 58: 571–578

    PubMed  Google Scholar 

  26. Rudman D, Kutner MH (1978) Melanotropic peptides increase permeability of plasma/cerebrospinal fluid barrier. Am J Physiol 234: E327–332

    PubMed  Google Scholar 

  27. Scheider A, Nasemann JE, Lund O-E (1993) Fluorescein and indocyanine green angiographies of central serous choroidpathy by scanning laser ophthalmoscope. Am J Ophthalmol 115: 50–56

    PubMed  Google Scholar 

  28. Spitznas M (1986) Pathogenesis of central serous retinopathy: a new working hypothesis. Graefe's Arch Clin Exp Ophthalmol 224: 321–324

    Google Scholar 

  29. Stroeva OG, Mitashov VI (1983) Retinal pigment epithelium: proliferation and differentiation during development and regeneration. Int Rev Cytol 83: 221–293

    PubMed  Google Scholar 

  30. Thorner MO, Vance ML, Horvath E, Kovacs K (1991) The anterior pituitary. In: Wilson JD, Foster DW (eds) Williams textbook of endocrinology, 8th edn. Saunders, Philadelphia, pp 225–226

    Google Scholar 

  31. Valentin JP, Wiedemann E, Humphreys MH (1993) Natriuretic properties of melanocyte-stimulating hormones. J Cardiovasc Pharmacol 22 [Suppl 2]: S114–118

    PubMed  Google Scholar 

  32. Wakakura M, Ishikawa S (1980) An evaluation of corticosteroid treatment for central serous chorioretinopathy (in Japanese) Rinsho Ganka 34: 123–129 (cited in [24])

    Google Scholar 

  33. Wakakura M, Ishikawa S (1984) Central serous chorioretinopathy complicating systemic corticosteroid treatment. Br J Ophthalmol 68: 329–331

    PubMed  Google Scholar 

  34. Williamson J, Dalakos TG (1967) Posterior subcapsular cataracts and macular lesions after long term corticotrophin therapy. Br J Ophthalmol 51: 839–842

    PubMed  Google Scholar 

  35. Williamson J, Nuki G (1970) Macular lesions during systemic therapy with depot tetracosactrin. Br J Ophthalmol 54: 405–409

    PubMed  Google Scholar 

  36. Yannuzzi LA (1987) Type-A behavior and central serous chorioretinopathy. Retina 7: 111–130

    PubMed  Google Scholar 

  37. Yoshioka H, Katsume Y, Akune H (1982) Experimental central serous chorioretinopathy in monkey eyes: fluorescein angiographic findings. Ophthalmologica 185: 168–178

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Ophthalmology, Hadassah University Hospital, P.O. Box 12000, 91120, Jerusalem, Israel

    Ehud Zamir

Authors
  1. Ehud Zamir
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zamir, E. Central serous retinopathy associated with adrenocorticotrophic hormone therapy. Graefe's Arch Clin Exp Ophthalmol 235, 339–344 (1997). https://doi.org/10.1007/BF00937280

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00937280

Keywords

Search

Navigation